SERENE LLC has a total of 17 patent applications. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and environmental technology are DEXTECH MEDICAL AB, CAMPBELL JAMES N and GALDERMA PHARMA SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | United States | 3 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Environmental technology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Climate change adaptation technologies | |
#5 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Stevenson Nigel R | 13 |
#2 | Simon Jaime | 9 |
#3 | Gonzales Gilbert R | 9 |
#4 | Cooper Lance | 6 |
#5 | Stevenson Nigel | 1 |
#6 | Gonzales Gilbert | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020257409A1 | A novel tin-117m colloid formulation with the ability to distinguish it from existing tin-117m colloid formulations | |
WO2019169241A1 | Methods of treating and imaging ungulate laminitis | |
EP3359202A1 | Hyaluronan sn-117m colloid for radiosynoviorthersis and symptomatic therapy related applications | |
CN108348619A | The dextran amine of the mannose coupling of SN-117M labels | |
EP3003400A1 | Treatment of immune, inflammatory and degenerative arthritides with tin-117m | |
EP2922578A1 | Tin-117m comprising somatostatin receptor binding compounds | |
EP2729185A1 | Apparatus for treating cholangiocarcinoma |